Patrick Jordan

As Chief Executive Officer of Mycovia Pharmaceuticals and Partner at NovaQuest Capital Management, Patrick Jordan creates and manages global biopharmaceutical investments and partnerships. He has more than 25 years of healthcare leadership in corporate development, operations, provider services and technology solutions. Prior to joining Mycovia and NovaQuest, Mr. Jordan led the creation of the Next Generation of Clinical Development Solutions at IQVIA, which used global data analytics to transform clinical research and was a central thesis in the merger of IMS Health and Quintiles. He previously led the management of Quintiles’ strategic accounts, and his team’s managed partnership process was recognized internationally. An original member of NovaQuest at its founding at Quintiles, Mr. Jordan led the group’s investment partnership strategy in Europe.

Mr. Jordan earned a BA from Duke University, an MA from the University of Durham, United Kingdom, and an MBA with a concentration in Health Sector Management from the Fuqua School of Business at Duke University.